90 results
DEFA14A
BMY
Bristol-Myers Squibb Co.
22 Apr 24
Additional proxy soliciting materials
8:16am
(Executive Director and above): 6.3% 6.5% 47.4% Black/African Hispanic/ Women American (U.S.) Latino (U.S.) (Global) 58%$1B Clinical trial sites in Global
DEFA14A
BMY
Bristol-Myers Squibb Co.
10 Apr 23
Additional proxy soliciting materials
5:12pm
in diverse metro areas 2022 Gender parity at executive level (VP+) globally 2X representation for Black/African American & Hispanic/Latino executives (VP … areas by the end of 2025 Spend $1 billion globally by 2025 with Black/African American and other diverse-owned businesses Achieve gender parity
SC TO-T
EX-99
y4ofkyt
17 Jun 22
Third party tender offer statement
4:42pm
8-K
EX-99.3
qxu5hhr2ml3wbqx5uk
29 Apr 22
Bristol Myers Squibb Reports First Quarter Financial Results for 2022
7:42am
DEFA14A
pfm02yp
20 Apr 22
Additional proxy soliciting materials
4:30pm
8-K
EX-99.3
gezpqy8elkj72hxq5k
4 Feb 22
Bristol Myers Squibb Reports Fourth Quarter and Full-Year Financial Results for 2021
7:50am
8-K
EX-99.1
scn6h
16 Nov 21
Regulation FD Disclosure
9:20am
8-K
EX-99.1
czca91e 79
27 Oct 21
Bristol Myers Squibb Reports Third Quarter Financial Results for 2021
9:46am
DEFA14A
ioypj
19 Apr 21
Additional proxy soliciting materials
7:41am
8-K
EX-99.1
oqum3trknk25c56t1vkz
5 Nov 20
Bristol Myers Squibb Reports Third Quarter 2020 Financial Results
8:10am
S-3ASR
g0e4jjyesik0sc
5 Feb 20
Automatic shelf registration
4:55pm